Effects of Denosumab on Bone Mineral Density, Markers of Bone Metabolism and Bone Microarchitecture in Women With Anorexia Nervosa: A Pilot Study
Phase of Trial: Phase 0
Latest Information Update: 25 Sep 2018
At a glance
- Drugs Denosumab (Primary)
- Indications Bone disorders
- Focus Therapeutic Use
- 13 Sep 2018 Planned End Date changed from 1 Apr 2020 to 1 May 2020.
- 13 Sep 2018 Planned primary completion date changed from 1 Oct 2019 to 1 May 2020.
- 27 Sep 2017 New trial record